Research-Driven Patient Care

As a cornerstone of the UK Gill Heart and Vascular Institute, our mission is to improve the cardiovascular health of Kentucky and the nation by uniting excellence in patient care with innovative research, outstanding education, and preventive efforts. Our vision is to be among the top  public cardiovascular programs in the country by providing research-driven patient care and applying the latest evidence and technology. Learn more about the institute.

Discoveries made by our physicians and scientists have provided new diagnostic tools, therapies, and better understanding of cardiovascular disease. We maintain a strong, consistent record of publications in the nation’s foremost peer-reviewed medical journals. We are also committed to educating physicians and scientists in training and disseminating knowledge to local communities about advances and emerging issues in cardiovascular disease. 

Through the newly established cardiovascular service line in 2025,  the division, department, college, and hospital enterprise is more fully aligned in the multidisciplinary clinical care delivery which includes board-certified adult and pediatric cardiologists, cardiothoracic surgeons, vascular surgeons, cardiac anesthesiologists, and cardiac and interventional radiologists working side-by-side in state-of-the-art facilities throughout UK Albert B. Chandler Hospital.  

Cardiovascular Medicine team forms a heart while wearing red

Our Mission

To improve the cardiovascular health of Kentucky and the nation by uniting excellence in patient care with groundbreaking research, outstanding education, and preventive efforts

Our Vision

To be among the top public cardiovascular programs in the country by providing research-driven patient care and applying the latest evidence and technology

Awards and Achievements

  • Awarded "High Performing Hospital for Heart Failure and Heart Attack" by the US News & World Report for 2024
  • Active participation in institution initiated, pharmacy and industry multi-center clinical trials and NIH-funded research initiatives 
  • Designated as a Gold Class Center by the International Cardio-Oncology Society since 2023
  • Accredited as an Adult Congenital Heart Association National Center of Excellence 2025
  • B. Wayne Hughes Program in Cardiovascular Innovation established in 2023; appointed the 1st B. Wayne Hughes Fellow in Interventional Cardiology in 2025
  • National and International recognized faculty who contribute to state-of-the-art clinical practice guidelines and consensus states and participate in leading edge scientific meetings